Your English writing platform
Discover LudwigSuggestions(2)
Exact(14)
Patients achieved pain relief without substantial adverse effects.
None of the patients, except one, achieved pain relief, i.e. decrease vs baseline 17% on VAS 0-10.
The majority of patients with mild or moderate migraine attacks achieved pain relief or pain-free status at both 1 and 2 h after nVNS treatment [26].
From a risk-benefit perspective, nVNS therapy achieved pain relief without serious side effects, which may decrease patients' reliance on migraine medications and, in turn, lower the risk of medication overuse.
To support his hypothesis, he points out that only around two-thirds of migraineurs receiving intravenous (IV) olcegepant achieved pain relief in 2 h, and 46% of patients had pain relief in 1 h [2], figures that are lower than previously reported values for subcutaneous sumatriptan [3].
Further, these patients achieved pain remission more often during the first year receiving standard care.
Similar(46)
Of these patients, 35.4 % and 39.6 % achieved pain-free status (VAS = 0) at 1 and 2 h, respectively.
Prolonged use also desensitizes opioid receptors, resulting in tolerance to oxycodone and necessitating increasing doses of the drug to achieve pain relief.
But while painkillers like Tylox contain five milligrams of oxycodone and require repeated doses to achieve pain relief, OxyContin contains 40 to 160 milligrams in a time-released formulation that controls pain over a longer period.
These acute responders were able to effectively treat 86% (4157/4811) of their attacks, with 57% (2750/4811) achieving pain freedom.
The value of oral analgesics is limited [3, 18], but local anaesthesia could be effective at achieving pain relief [3].
Write better and faster with AI suggestions while staying true to your unique style.
Since I tried Ludwig back in 2017, I have been constantly using it in both editing and translation. Ever since, I suggest it to my translators at ProSciEditing.

Justyna Jupowicz-Kozak
CEO of Professional Science Editing for Scientists @ prosciediting.com